Skip to Content
Merck
CN

Key Documents

View All Documentation

416200

Dipeptidylpeptidase IV inhibitor I

≥95% (HPLC), amorphous solid

Synonym(s):

Dipeptidylpeptidase IV Inhibitor I, Diprotin A

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C17H31N3O4
Molecular Weight:
341.45
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥95% (HPLC)
Form:
amorphous solid
Quality level:
100
Storage condition:
OK to freeze, desiccated (hygroscopic)
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Dipeptidylpeptidase IV Inhibitor I, The Dipeptidylpeptidase IV Inhibitor I controls the biological activity of Dipeptidylpeptidase IV. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

Quality Level

100

assay

≥95% (HPLC)

form

amorphous solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, desiccated (hygroscopic)

color

white

solubility

water: 1 mg/mL, DMSO: 5 mg/mL

shipped in

ambient

storage temp.

2-8°C

General description

A dipeptidylpeptidase IV (DPP IV) inhibitor that inhibits both endo- and exopeptidase activities of DPPIV.

Biochem/physiol Actions

Cell permeable: no
Primary Target
dipeptidylpeptidase IV (DPP IV)
Product does not compete with ATP.
Reversible: no

Preparation Note

Following reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.

Other Notes

Ile-Pro-Ile

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)

Still not finding the right product?

Explore all of our products under Dipeptidylpeptidase IV Inhibitor I

Storage Class

11 - Combustible Solids

wgk

WGK 3

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hyunyee Yoon et al.
Biomolecules & therapeutics, 29(2), 154-165 (2020-11-06)
This study aimed to investigate whether the antidiabetic drugs dipeptidyl peptidase 4 (DPP4) inhibitors such as evogliptin and sitagliptin affect the membrane DPP4 (mDPP4) enzymatic activity and immune function of T helper1 (Th1) cells in terms of cytokine expression and

Global Trade Item Number

SKUGTIN
416200-5MG04055977187809